SISTEMA DE FIJACIÓN INTERESPINOSO NOVAXDMA
Mexico·Clase III·II. PROSTHETICS, ORTHOSES AND FUNCTIONAL AIDS·MANDALA MÉXICO LEGAL AFFAIRS, S.A. DE C.V.·Registered February 12, 2019EL DISPOSITIVO ESTÁ INDICADO PARA: • ENFERMEDAD DEGENERATIVA DISCAL: HERNIA DISCAL, DOLOR ARTICULAR ARTRÓSICO, INESTABILIDAD SEGMENTARIA • CONDUCTO RAQUÍDEO ESTRECHO: ARTRÓSICO: CENTRAL O LATERAL POR ESPONDILOLISTESIS DEGENERATIVA. • ESTENOSIS FORAMIN
THE DEVICE IS INDICATED FOR: • DEGENERATIVE DISC DISEASE: HERNIATED DISC, ARTHRITIC JOINT PAIN, SEGMENTAL INSTABILITY • NARROW SPINAL CANAL: ARTHRITIC: CENTRAL OR LATERAL DUE TO DEGENERATIVE SPONDYLOLISTHESIS. • FORAMIN STENOSIS
- Risk Class / Clase de Riesgo
- Clase III
- Product Type (Spanish)
- II. PROTESIS, ÓRTESIS Y AYUDAS FUNCIONALES
- Product Type (English)
- II. PROSTHETICS, ORTHOSES AND FUNCTIONAL AIDS
- Trade Name (Spanish)
- SISTEMA DE FIJACIÓN INTERESPINOSO PARA COLUMNA VERTEBRAL DE POLIÉTER ÉTER CETONA (PEEK)
- Trade Name (English)
- INTERSPINOUS FIXATION SYSTEM FOR POLYETHER ETHER KETONE (PEEK) SPINE
- Analysis ID
- 257C2019 SSA
- Registration Date
- February 12, 2019
- Name (Spanish)
- MANDALA MÉXICO LEGAL AFFAIRS, S.A. DE C.V.
- Name (English)
- MANDALA MÉXICO LEGAL AFFAIRS, S.A. DE C.V.
Access comprehensive regulatory information for SISTEMA DE FIJACIÓN INTERESPINOSO NOVAXDMA (NOVAXDMA INTERSPINOUS FIXATION SYSTEM) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 257C2019 SSA and manufactured by MANDALA MÉXICO LEGAL AFFAIRS, S.A. DE C.V.. The device was registered on February 12, 2019.
This page provides complete registration details including product type (II. PROSTHETICS, ORTHOSES AND FUNCTIONAL AIDS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.